Please login to the form below
UDG Healthcare appoints Jez Moulding as Group Chief Operating Officer and Executive Vice President of Ashfield
UDG Healthcare plc (“the Group”), a leading international healthcare services provider, is pleased to announce the appointment of Jez Moulding as Chief Operating Officer (“COO”) of UDG Healthcare plc and Executive Vice President of Ashfield with effect from 2 May 2017
Jez
will oversee the Ashfield Division globally and will also have responsibility
for Group IT, Quality, Compliance, Strategy and Communications as part of his
role as COO of UDG Healthcare plc. The Sharp and Aquilant divisions will
continue to report directly to Brendan McAtamney, CEO of UDG Healthcare plc.
Jez brings extensive international pharmaceutical experience to UDG having spent 18 years at Sanofi, holding numerous senior leadership positions across the globe, in the UK, France, South Africa, Korea, Australia, Japan and the US. In his most recent role as Senior Vice President and North America Region Head for Diabetes and Cardiovascular, he was responsible for 3,500 employees and sales of over $5 billion. Prior to joining Sanofi in 1999, Jez held a variety of positions at Astra Pharmaceuticals and Winchester Pharmaceuticals in the UK.
Brendan McAtamney, CEO of UDG Healthcare, said: “We are delighted to welcome Jez to UDG Healthcare and to Ashfield. He has extensive leadership experience in the pharmaceutical sector within our key global markets. His most recent experience leading the Sanofi North American business will be extremely valuable to us as we continue to develop our Ashfield US business and expand the Group internationally.”
Jez Moulding, incoming COO of UDG Healthcare plc and Executive Vice President of Ashfield, said: “I am thrilled to be joining such a fast growing, dynamic team in Ashfield and UDG Healthcare. Ashfield has grown over many years and is a market leader in commercialisation services to global pharmaceutical clients. I look forward to building on this strong platform and driving further international expansion across the Group.”
As previously announced, Chris Corbin will transition to the role of Chairman of Ashfield and continue as a Non-Executive Director of UDG Healthcare.
For more information on Ashfield please click here, and for more information on UDG Healthcare please click here
Jez brings extensive international pharmaceutical experience to UDG having spent 18 years at Sanofi, holding numerous senior leadership positions across the globe, in the UK, France, South Africa, Korea, Australia, Japan and the US. In his most recent role as Senior Vice President and North America Region Head for Diabetes and Cardiovascular, he was responsible for 3,500 employees and sales of over $5 billion. Prior to joining Sanofi in 1999, Jez held a variety of positions at Astra Pharmaceuticals and Winchester Pharmaceuticals in the UK.
Brendan McAtamney, CEO of UDG Healthcare, said: “We are delighted to welcome Jez to UDG Healthcare and to Ashfield. He has extensive leadership experience in the pharmaceutical sector within our key global markets. His most recent experience leading the Sanofi North American business will be extremely valuable to us as we continue to develop our Ashfield US business and expand the Group internationally.”
Jez Moulding, incoming COO of UDG Healthcare plc and Executive Vice President of Ashfield, said: “I am thrilled to be joining such a fast growing, dynamic team in Ashfield and UDG Healthcare. Ashfield has grown over many years and is a market leader in commercialisation services to global pharmaceutical clients. I look forward to building on this strong platform and driving further international expansion across the Group.”
As previously announced, Chris Corbin will transition to the role of Chairman of Ashfield and continue as a Non-Executive Director of UDG Healthcare.
For more information on Ashfield please click here, and for more information on UDG Healthcare please click here
Company Details
Ashfield
Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK
Latest content on this profile
- Ashfield Healthcare Communications announces two new alliances with Argon Global Healthcare and MIMS
Ashfield
- Caitlin qualifies as ‘Mental Health Champion’
- Project Manager uses personal development funding to support friends' and colleagues' well-being – by Helen Capelin Head of Operational Excellence.
Ashfield
- Ashfield Healthcare Communications is now in Manchester!
- We are happy to announce that we have officially moved into our Manchester office! This will be our 16th office for Ashfield Healthcare Communications along with our others across Europe, America, and Asia-Pacific.
Ashfield
- A reflection of ESMO
- Client Relationship Director Fabienne Wild from Ashfield Meetings & Events reflects on the recent conference season and on her experience at the European Society for Medical Oncology (ESMO).
Ashfield
- Ashfield releases new Divisional Casebook – stories of collaboration, innovation and success
- Today's healthcare companies are looking for an agile and responsive partner to help them overcome complex challenges, deliver innovative products and break into new markets.
Ashfield
- Allegro welcomes third intake of aspiring medical writers to fast-track training programme
- Ashfield Healthcare Communications, a leading global healthcare communications agency, today welcomes its third intake of aspiring medical writers into its accelerated medical writing training programme, Allegro.
Ashfield
